Mablink Bioscience
Biotechnology, Pharmaceutical
Founded in 1/1/18
Lyon, Rhone-Alpes, France
For Profit
About Mablink Bioscience
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 35000000 EUR
- Last Funding: 31000000 EUR (Series A)
- Funding Status: Early Stage Venture
Technology Stack
Mablink Bioscience actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Pharmaceutical
Headquarters: Lyon, Rhone-Alpes, France
Employees
- Edouard Leroy - Chief Business Officer (LinkedIn)
- Stanislas Sordet - Chief Financial Officer (LinkedIn)
- Warren Viricel - Co-founder & Chief Scientific Officer (LinkedIn)